← Open Payments lookup

JACOB MALONE: Open Payments

NPI 1851043947 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,360 in 55 payments from 16 companies in 2025. Trend: 2023 $1,071 · 2024 $775 · 2025 $1,360

Food & beverage: $1,360
CompanyPaymentsAmount
Alnylam Pharmaceuticals Inc.6$257
E.R. Squibb & Sons, L.L.C.8$254
Edwards Lifesciences Corporation1$160
Daiichi Sankyo Inc.6$105
Novartis Pharmaceuticals Corporation5$85
Merck Sharp & Dohme LLC5$83
Novo Nordisk Inc5$82
Bayer Healthcare Pharmaceuticals Inc.4$77
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)4$66
Amgen Inc.3$47

Products named: AMVUTTRA, SAPIEN 3 Ultra RESILIA, CAMZYOS, INJECTAFER, ONPATTRO, LEQVIO, Wegovy, Kerendia.

Industry payments across OK — which companies pay providers there.